Tesamorelin / CJC-1295 / Ipamorelin (12 mg / 6 mg / 6 mg) is a research-grade peptide blend studied for its role in supporting growth hormone signaling and metabolic regulation. This formulation is designed to help promote healthy growth hormone activity, support cellular recovery processes, and maintain balanced metabolic function. The combination of these peptides is researched for its potential influence on pathways related to body composition, energy metabolism, and tissue repair, making it a compound of interest for studies focused on metabolic optimization, physical performance, and overall cellular health.
The Tesamorelin / CJC-1295 / Ipamorelin (12mg / 6mg / 6mg) triple-peptide blend is a premier research configuration designed to explore maximum growth hormone (GH) secretagogue synergy. By combining two distinct GHRH receptor agonists with a highly selective GHRP pentapeptide, this formulation serves as an advanced investigative tool for tracking accelerated visceral lipolysis, lean tissue repair, and metabolic efficiency in laboratory models.
Supplied as a stable, high-purity lyophilized powder blend in a single 24mg total mass vial. Restricted strictly to laboratory and in vitro research applications.